Effects of probiotics on quality of life in children with cystic fibrosis; A randomized controlled trial

Iranian Journal of Pediatrics

Volumn 23, Issue 6, 2013, Pages 669-674

  Jafari, Seyed Ali ^a   Mehdizadeh Hakkak, Atieh ^b   Kianifar, Hamid Reza ^c   Hebrani, Paria ^d   Ahanchian, Hamid ^e   Abbasnejad, Elaheh ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cystic fibrosis; Probiotics; Pulmonary exacerbation; Quality of life

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; PEDIATRIC QUALITY OF LIFE INVENTORY; PRESCHOOL CHILD; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 84890469591     PISSN: 20082142     EISSN: 20082150     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168(8): 918-51.
2. van Elburg RM, Uil JJ, van Aalderen WMC, et al. Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis. Pediatr Res 1996;39(6):985-91.
3. Claeys S, van Hoecke H, Holtappels G, et al. Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators. Clin Exp Allergy 2005;35(4):467-72.
4. Bruzzese E, Raia V, Gaudiello G, et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 2004;20(7):813-9.
5. Infante Pina D, Redecillas Ferreiro S, Torrent Vernetta A, et al. Improvement of intestinal function in cystic fibrosis patients using probiotics. Ann Pediatr (Barc) 2008;69(6):501-5.
6. Young RJ, Huffman S. Probiotic use in children. J Pediatr Health Care 2003;17(6):277-83.
7. Homayouni Rad A, Torab R, Ghalibaf M, et al. Might patients with immune-related diseases benefit from probiotics? Nutrition 2013;29(3):583-6.
8. Allen SJ, Okoko B, Martinez E, et al. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2004(2):CD003048.
9. Kalliomaki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-years follow-up of a randomised placebo-controlled trial. Lancet 2003;361(9372):1869-71.
10. Khodada A, Farahmand F, Mehri N, et al. Probiotics for the treatment of pediatric helicobacter pylori infection: a randomized double blind clinical trial. Iran J Pediatr 2013;23(1):79-84.
11. Weiss B, Bujanover Y, Yahav Y, et al. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Pediatr Pulmonol 2010;45(6):536-40.
12. Bruzzese E, Raia V, Spagnuolo MI, et al. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: A pilot study. Clin Nutr 2007;26(3):322-8.
13. Perdigon G, Fuller R, Raya R. Lactic acid bacteria and their effect on the immune system. Curr Issues Interest Microbiol 2001;2(1):27-42.
14. Schmitz TG, Goldbeck L. The effect of inpatient rehabilitation programmes on quality of life in patients with cystic fibrosis: A multi-center study. Health Qual Life Outcomes 2006;4:8.
15. Cohen-Cymberknoh M, Shoseyov D, Kerem E. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am J Respir Crit Care Med 2011;183(11):1463-71.
16. Varni JW, Burwinkle TM, Seid M. The PedsQL™ as a pediatric patient-reported outcome: Reliability and validity of the PedsQL™ Measurement Model in 25, 000 children. Expert Rev Pharmacoecon Outcomes Res 2005;5(6):705-19.
17. Varni JW, Burwinkle TM, Seid M. The PedsQL™ 4.0 as a school population health measure: Feasibility, reliability, and validity. Qual Life Res 2006;15(2): 203-15.
18. Bastiaansen D, Koot HM, Bongers IL, et al. Measuring quality of life in children referred for psychiatric problems: Psychometric properties of the PedsQL™ 4.0 Generic Core Scales. Qual Life Res 2004;13(2): 489-95.
19. Follow guidelines in Cystic Fibrosis Foundation. Mycrobiology and infectious disease in Cystic Fibrosis. Consensus Conferences: Concept in care. Bethesda, 1994, Vol V, sect 1.
20. Alverez S, Herrero C, Bru E, et al. Effect of Lactobacillus casei and yogurt administration on prevention of Pseudomonas aeruginosa infection in young mice. J Food Prot 2001;64(11):1768-74.
21. Valdez JC, Peral MC, Rachid M, et al. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment. Clin Microbiol Infect 2005;11(6):472-9.
22. Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-alpha-and IFN-gammainduced dysfunction in human intestinal epithelial cells. Gastroenterology 2006;130(3):731-46.
23. Neil FR, Albert DL. Probiotics in the treatment of human inflammatory bowel diseases: update 2008. J Clin Gastroenterol 2008;42 (Suppl 2):S97-103.
24. Heydarian F, Kianifar HR, Ahanchian H, et al. A comparison between traditional yogurt and probiotic yogurt in non-inflammatory acute gastroenteritis. Saudi Med J 2010;31(3):280-3.
25. Kianifar HR, Farid R, Ahanchian H, et al. Probiotics in the treatment of acute diarrhea in young children. Iran J Med Sci 2009;34(3):204-7.
26. Homayouni Rad A, Torab R, Mortazavian AM, et al. Can probiotics prevent or improve common cold and influenza? Nutrition 2013; 29(5):805-6.
27. Ejtehad HS, Mohtadi-Nia J, Homayouni-Rad A, et al. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012; 28(5):539-43.
28. Bruzzese E, Raia V, Spagnuolo MI, et al. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clin Nutr 2007; 26(3):322-8.
29. Corey M, McLaughlin FJ, Williams M, et al. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41(6):583-91.
30. Kianifar HR, Bakhshoodeh B, Hebrani P, et al. Qulaity of life in cystic fibrosis children. Iran J Pediatr 2013;23(2):149-53.